COVID-19 and chronic kidney disease: an updated overview of reviews.

ABSTRACT:

Background

Coronavirus disease (COVID-19) has resulted in the death of more than 3.5 million people worldwide. While COVID-19 mostly affects the lungs, different comorbidities can have an impact on its outcomes. We performed an overview of reviews to assess the effect of Chronic Kidney Disease (CKD) on contracting COVID-19, hospitalization, mortality, and disease severity.

Methods

We searched published and preprint databases. We updated the reviews by searching for primary studies published after August 2020, and prioritized reviews that are most updated and of higher quality using the AMSTAR tool.

Results

We included 69 systematic reviews and 66 primary studies. Twenty-eight reviews reported on the prevalence of CKD among patients with COVID-19, which ranged from 0.4

SUBMITTER: Jdiaa SS 

PROVIDER: S-EPMC8747880 | biostudies-literature | 2022 Jan

REPOSITORIES: biostudies-literature